After Glaxo's genital herpes vaccine flop, check out Agenus Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : After Glaxo's genital herpes vaccine flop, check out Agenus

GSK 46.86

-0.2%

Oct 31 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: albertaft	1/18/2015 8:55:59 PM
	Read Replies (1) of 22

Okay Bob, my pleasure. That's a good point. Not only has Gates mentioned dumping money in with the Ebola vaccine coming out now, but Glaxo may also be responsible for eradicating Ebola. And the price is at $43? There hasn't been an emerging disease outbreak like this in modern times and this is a very unique event, and with a vaccine. First of its kind event. Again, I launched the forum at avianflutalk.com back in 2005 and have been tracking these things (and pandemic threats) for many years. I also launched swineflu.org back in 2009 and Ebolainfo.org early last year. Believe me, I know who's about to come out with the Ebola vaccine and when. I also know what that will do to a share price. I wouldn't doubt to see a 200% - 300% gain. But - everyone should do their own research and this is what I personally believe and have heard. Best of luck!

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next